Pan-Biome Pharmaceuticals, Inc. provides update on its longevity research program: its compounds modulate inflammation, the gut microbiome, and increase lifespan of C. elegans by 30%
December 02, 2021 10:00 ET | Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc., a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
Derm-Biome Pharmaceuticals, Inc. adds skin disease and microbiome specialists Drs. Youwen Zhou and Andy Sham to Its Newly Created Scientific Advisory Board
June 02, 2021 08:00 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin health and healthy ageing,...
Blue California Opens New Possibilities in Functional Food and Beverages Following Dihydroquercetin (DHQ) GRAS Status
May 25, 2021 05:39 ET | Blue California Ingredients
Rancho Santa Margarita, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Blue California’s Taxifolin BC-DHQ® with super antioxidant and anti-inflammatory properties is now Generally Recognized As Safe...
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
February 24, 2021 10:00 ET | Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
Blue California Files Patent on the Use of Ergothioneine as a Support for Oxidative Stress Related Health Conditions, including COVID-19
July 14, 2020 17:37 ET | Blue California Ingredients
Rancho Santa Margarita, Calif and Bedford, Mass., July 14, 2020 (GLOBE NEWSWIRE) -- Blue California, a science-based, innovative ingredient solution provider, has just filed for a patent on...
Reports and Data.jpeg-01
Lactoferrin Market To Reach USD 329.7 Million By 2026 | Reports And Data
January 28, 2020 14:00 ET | Reports and Data
New York, Jan. 28, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Lactoferrin market was valued at USD 189.6 million in 2018 and is expected to reach USD...
Business Capital Delivers $5.5 Million Financing for Wedderspoon
January 14, 2020 07:00 ET | Business Capital
SAN FRANCISCO, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Business Capital structured and delivered a $5.5MM  working capital facility for Wedderspoon, the largest seller of Manuka honey and its portfolio of...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Develops Glucoraphanin + NanoStilbene Encapsulated product for reduction of Prostate Specific Antigen (PSA)
July 08, 2019 09:00 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced today the development of a broccoli sprout extract...
Addivant™ Receives Formal Food-Contact Approval From MERCOSUR Region For WESTON® 705 Nonylphenol-Free Antioxidant
August 28, 2018 10:13 ET | Addivant
DANBURY, Conn., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Addivant™, the world leading supplier of liquid phosphite antioxidants for plastics, announced today that its nonylphenol-free stabilizer, WESTON®...
Nutrex Hawaii Earns IGEN™ Verification for its BioAstin® Hawaiian Astaxanthin® Natural Microalgae Products
March 06, 2018 06:00 ET | Nutrex Hawaii
KAILUA-KONA, Hawaii, March 06, 2018 (GLOBE NEWSWIRE) -- Nutrex Hawaii, Inc. is pleased to announce that its BioAstin® Hawaiian Astaxanthin® and MD Formulas™ have received The International GMO...